The CC16 A38G polymorphism is associated with asymptomatic airway hyper-responsiveness and development of late-onset asthma

Natsuko Taniguchi, Satoshi Konno, Takeshi Hattori, Akira Isada, Kaoruko Shimizu, Kenichi Shimizu, Noriharu Shijubo, Shau Ku Huang, Nobuyuki Hizawa, Masaharu Nishimura

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background Clara cell secretory protein (CC16) is expressed primarily in the respiratory tract and is a potent anti-inflammatory agent that protects the airway from inflammation. The associations of the A38G polymorphism in this gene with asymptomatic airway hyper-responsiveness (AHR), which is considered a risk factor for future asthma in adults, and the development of adult-onset asthma are unclear. Objective To evaluate the association of the CC16 A38G polymorphism with asymptomatic AHR in healthy young adults and the development of adult-onset asthma and the association between plasma CC16 level according to this genotype and asymptomatic AHR. Methods Nonspecific AHR was measured in 154 asymptomatic, young, healthy adults using a continuous methacholine inhalation method. The cumulative dose values of inhaled methacholine measured at the inflection point at which respiratory conductance started to decrease (Dmin) were used as an index of AHR. Case-control analysis was performed for the association between this polymorphism and the development of asthma in 1,086 unrelated Japanese subjects (504 subjects with asthma and 582 healthy subjects). Results The 38AA + AG genotype was associated with lower Dmin values and lower plasma CC16 levels (P =.012 and.020). There was a significant positive correlation between Dmin values and plasma CC16 levels (P =.012). In the case-control study, the 38AA + AG genotype was significantly associated with late-onset asthma (onset at >40 years; odds ratio, 1.63; P =.016). Conclusion These results suggest that the CC16 A38G polymorphism may play a role in asymptomatic AHR and contribute to the development of late-onset asthma.

Original languageEnglish
Pages (from-to)376-381
Number of pages6
JournalAnnals of Allergy, Asthma and Immunology
Volume111
Issue number5
DOIs
Publication statusPublished - Nov 1 2013
Externally publishedYes

Fingerprint

Respiratory Hypersensitivity
Asthma
Methacholine Chloride
Genotype
Young Adult
Uteroglobin
Respiratory System
Inhalation
Case-Control Studies
Healthy Volunteers
Anti-Inflammatory Agents
Odds Ratio
Inflammation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

The CC16 A38G polymorphism is associated with asymptomatic airway hyper-responsiveness and development of late-onset asthma. / Taniguchi, Natsuko; Konno, Satoshi; Hattori, Takeshi; Isada, Akira; Shimizu, Kaoruko; Shimizu, Kenichi; Shijubo, Noriharu; Huang, Shau Ku; Hizawa, Nobuyuki; Nishimura, Masaharu.

In: Annals of Allergy, Asthma and Immunology, Vol. 111, No. 5, 01.11.2013, p. 376-381.

Research output: Contribution to journalArticle

Taniguchi, N, Konno, S, Hattori, T, Isada, A, Shimizu, K, Shimizu, K, Shijubo, N, Huang, SK, Hizawa, N & Nishimura, M 2013, 'The CC16 A38G polymorphism is associated with asymptomatic airway hyper-responsiveness and development of late-onset asthma', Annals of Allergy, Asthma and Immunology, vol. 111, no. 5, pp. 376-381. https://doi.org/10.1016/j.anai.2013.08.005
Taniguchi, Natsuko ; Konno, Satoshi ; Hattori, Takeshi ; Isada, Akira ; Shimizu, Kaoruko ; Shimizu, Kenichi ; Shijubo, Noriharu ; Huang, Shau Ku ; Hizawa, Nobuyuki ; Nishimura, Masaharu. / The CC16 A38G polymorphism is associated with asymptomatic airway hyper-responsiveness and development of late-onset asthma. In: Annals of Allergy, Asthma and Immunology. 2013 ; Vol. 111, No. 5. pp. 376-381.
@article{3accee501e0f4fa7a9d9f425a7ca2770,
title = "The CC16 A38G polymorphism is associated with asymptomatic airway hyper-responsiveness and development of late-onset asthma",
abstract = "Background Clara cell secretory protein (CC16) is expressed primarily in the respiratory tract and is a potent anti-inflammatory agent that protects the airway from inflammation. The associations of the A38G polymorphism in this gene with asymptomatic airway hyper-responsiveness (AHR), which is considered a risk factor for future asthma in adults, and the development of adult-onset asthma are unclear. Objective To evaluate the association of the CC16 A38G polymorphism with asymptomatic AHR in healthy young adults and the development of adult-onset asthma and the association between plasma CC16 level according to this genotype and asymptomatic AHR. Methods Nonspecific AHR was measured in 154 asymptomatic, young, healthy adults using a continuous methacholine inhalation method. The cumulative dose values of inhaled methacholine measured at the inflection point at which respiratory conductance started to decrease (Dmin) were used as an index of AHR. Case-control analysis was performed for the association between this polymorphism and the development of asthma in 1,086 unrelated Japanese subjects (504 subjects with asthma and 582 healthy subjects). Results The 38AA + AG genotype was associated with lower Dmin values and lower plasma CC16 levels (P =.012 and.020). There was a significant positive correlation between Dmin values and plasma CC16 levels (P =.012). In the case-control study, the 38AA + AG genotype was significantly associated with late-onset asthma (onset at >40 years; odds ratio, 1.63; P =.016). Conclusion These results suggest that the CC16 A38G polymorphism may play a role in asymptomatic AHR and contribute to the development of late-onset asthma.",
author = "Natsuko Taniguchi and Satoshi Konno and Takeshi Hattori and Akira Isada and Kaoruko Shimizu and Kenichi Shimizu and Noriharu Shijubo and Huang, {Shau Ku} and Nobuyuki Hizawa and Masaharu Nishimura",
year = "2013",
month = "11",
day = "1",
doi = "10.1016/j.anai.2013.08.005",
language = "English",
volume = "111",
pages = "376--381",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "5",

}

TY - JOUR

T1 - The CC16 A38G polymorphism is associated with asymptomatic airway hyper-responsiveness and development of late-onset asthma

AU - Taniguchi, Natsuko

AU - Konno, Satoshi

AU - Hattori, Takeshi

AU - Isada, Akira

AU - Shimizu, Kaoruko

AU - Shimizu, Kenichi

AU - Shijubo, Noriharu

AU - Huang, Shau Ku

AU - Hizawa, Nobuyuki

AU - Nishimura, Masaharu

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Background Clara cell secretory protein (CC16) is expressed primarily in the respiratory tract and is a potent anti-inflammatory agent that protects the airway from inflammation. The associations of the A38G polymorphism in this gene with asymptomatic airway hyper-responsiveness (AHR), which is considered a risk factor for future asthma in adults, and the development of adult-onset asthma are unclear. Objective To evaluate the association of the CC16 A38G polymorphism with asymptomatic AHR in healthy young adults and the development of adult-onset asthma and the association between plasma CC16 level according to this genotype and asymptomatic AHR. Methods Nonspecific AHR was measured in 154 asymptomatic, young, healthy adults using a continuous methacholine inhalation method. The cumulative dose values of inhaled methacholine measured at the inflection point at which respiratory conductance started to decrease (Dmin) were used as an index of AHR. Case-control analysis was performed for the association between this polymorphism and the development of asthma in 1,086 unrelated Japanese subjects (504 subjects with asthma and 582 healthy subjects). Results The 38AA + AG genotype was associated with lower Dmin values and lower plasma CC16 levels (P =.012 and.020). There was a significant positive correlation between Dmin values and plasma CC16 levels (P =.012). In the case-control study, the 38AA + AG genotype was significantly associated with late-onset asthma (onset at >40 years; odds ratio, 1.63; P =.016). Conclusion These results suggest that the CC16 A38G polymorphism may play a role in asymptomatic AHR and contribute to the development of late-onset asthma.

AB - Background Clara cell secretory protein (CC16) is expressed primarily in the respiratory tract and is a potent anti-inflammatory agent that protects the airway from inflammation. The associations of the A38G polymorphism in this gene with asymptomatic airway hyper-responsiveness (AHR), which is considered a risk factor for future asthma in adults, and the development of adult-onset asthma are unclear. Objective To evaluate the association of the CC16 A38G polymorphism with asymptomatic AHR in healthy young adults and the development of adult-onset asthma and the association between plasma CC16 level according to this genotype and asymptomatic AHR. Methods Nonspecific AHR was measured in 154 asymptomatic, young, healthy adults using a continuous methacholine inhalation method. The cumulative dose values of inhaled methacholine measured at the inflection point at which respiratory conductance started to decrease (Dmin) were used as an index of AHR. Case-control analysis was performed for the association between this polymorphism and the development of asthma in 1,086 unrelated Japanese subjects (504 subjects with asthma and 582 healthy subjects). Results The 38AA + AG genotype was associated with lower Dmin values and lower plasma CC16 levels (P =.012 and.020). There was a significant positive correlation between Dmin values and plasma CC16 levels (P =.012). In the case-control study, the 38AA + AG genotype was significantly associated with late-onset asthma (onset at >40 years; odds ratio, 1.63; P =.016). Conclusion These results suggest that the CC16 A38G polymorphism may play a role in asymptomatic AHR and contribute to the development of late-onset asthma.

UR - http://www.scopus.com/inward/record.url?scp=84885955697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885955697&partnerID=8YFLogxK

U2 - 10.1016/j.anai.2013.08.005

DO - 10.1016/j.anai.2013.08.005

M3 - Article

C2 - 24125144

AN - SCOPUS:84885955697

VL - 111

SP - 376

EP - 381

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 5

ER -